Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Beta-1 adrenergic receptor
Species	Rattus norvegicus (Rat)
Gene	Adrb1
Synonym	adrenergic receptor beta1-adrenoceptor Beta-1 adrenoreceptor Beta-1 adrenoceptor beta-1 adrenergic receptor ADRB1R beta 1-AR B1AR Adrenergic receptor beta 1 Adrb-1 [ Show all ]
Disease	N/A for non-human GPCRs
Length	466
Amino acid sequence	MGAGALALGASEPCNLSSAAPLPDGAATAARLLVLASPPASLLPPASEGSAPLSQQWTAGMGLLLALIVLLIVVGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITLPFRYQSLLTRARARALVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLTGPPRPPSPAPSPSPGPPRPADSLANGRSSKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRDLVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAACRRRAAHGDRPRASGCLARAGPPPSPGAPSDDDDDDAGATPPARLLEPWAGCNGGTTTVDSDSSLDEPGRQGFSSESKV
UniProt	P18090
Protein Data Bank	N/A
GPCR-HGmod model	N/A
3D structure model	No available structures or models
BioLiP	N/A
Therapeutic Target Database	N/A
ChEMBL	CHEMBL3252
IUPHAR	N/A
DrugBank	N/A

Ligand

Name	naftopidil
Molecular formula	C24H28N2O3
IUPAC name	1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol
Molecular weight	392.499
Hydrogen bond acceptor	5
Hydrogen bond donor	1
XlogP	4.1
Synonyms	HMS3655H21 1-(4-(2-methoxyphenyl)piperazin-1-yl)- MFCD11046013 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;hydrochloride Naftopidil (unspecified) 4-(2-Methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-pioerazineethanol NCGC00015718-04 AB00489961-18 NCGC00024672-04 AKOS002279617 Prestwick3_000975 BDBM50773 SMR000466346 CAS-57149-07-2 CPD000466346 DTXSID5045176 Flivas (TN) KT-611 1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthalenyloxy)-2-propanol;hydrochloride MolPort-003-849-303 1-[4-(2-methoxyphenyl)piperazinyl]-3-naphthyloxypropan-2-ol Naftopidil [INN] 4-(2-methoxyphenyl)-\|A-((1-naphthalenyloxy)methyl)-1-piperazineethanol NCGC00015718-08 AB00489961_21 O220 Avishot SAM001246658 BRD-A01787639-300-03-7 ST50794017 CHEBI:31891 D04DKH HMS2089G07 (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol LS-112431 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxy-propan-2-ol;hydrochloride Naftopidil (Flivas) 27822-EP2314587A1 Naftopidilum [Latin] 57149-07-2 NCGC00015718-12 AC1L1I4G Prestwick1_000975 BCP21786 SC-25905 BSPBio_001009 Tox21_110205 cid_4418 DSSTox_GSID_45176 FE-0209 HY-B0391 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol MLS000759459 1-[4-(2-methoxyphenyl)piperazino]-3-(1-naphthoxy)propan-2-ol;hydrochloride Naftopidil orally disintegrating tablets (JP17) 4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol NCGC00015718-05 AB00489961-19 NSC-759293 AKOS016328058 REGID_for_CID_4418 BM-15275 SPBio_002920 CCG-100935 CS-2477 FT-0630696 (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol KT-611;BM-15275;Avishot;Flivas 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol N0832 27822-EP2270011A1 Naftopidil,(S) 49N072 NCGC00015718-09 AB00514643 Pharmakon1600-01506024 BBL028454 SB19321 BRD-A01787639-300-04-5 STL372645 DB12092 HMS3393B09 1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol MCULE-8827578135 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol Naftopidil (JP17/INN) 3-(naphthalen-1-yloxy)propan-2-ol NC00185 AB0016337 NCGC00024672-03 AC1Q77IN Prestwick2_000975 BCP9000976 SCHEMBL113215 C24H28N2O3 Tox21_110205_1 cid_6603044 DSSTox_RID_80725 Flivas KS-00000XJU 1-Pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)- MLS001424117 1-[4-(2-Methoxyphenyl)piperazinyl]-3-(1-naphthyloxy)propan-2-ol Naftopidil tablets (JP17) 4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol hydrochloride hydrate NCGC00015718-06 AB00489961_20 NSC759293 AN-40014 s2126 BPBio1_001111 ST24048774 CCG-205022 D01674 HMS2051B09 (+-)-4-(o-Methoxyphenyl)-alpha-((1-naphthyloxy)methyl)-1-piperazineethanol Lopac0_000941 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol 27822-EP2298767A1 Naftopidilum NCGC00015718-10 AB2000527 Prestwick0_000975 BC205447 SBI-0050915.P002 BRN 0629965 SW196570-4 CHEMBL142635 DSSTox_CID_25176 [ Show all ]
Inchi Key	HRRBJVNMSRJFHQ-UHFFFAOYSA-N
Inchi ID	InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3
PubChem CID	4418
ChEMBL	CHEMBL142635
IUPHAR	N/A
BindingDB	50773
DrugBank	N/A
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Ki	<1000.0 nM	PMID10743949	BindingDB,ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417